Dyspnea Clinical Trial
Official title:
Non-invasive Evaluation of Cardiopulmonary Diseases Using Transthoracic Parametric Doppler Based Assessment of Lung Doppler Signals
Historically, ultrasound imaging of the lung parenchyma has been challenging because of the
high total ultrasound energy attenuation and scattering by the air in the lungs. However,
recent technological advancements have allowed for rapid assessment of various pulmonary
diseases via the use of lung ultrasound. Furthermore, it has been shown that clear
reproducible Doppler signals can be recorded from the lung parenchyma by means of a pulsed
Doppler ultrasound system incorporating a special signal-processing package.
The LDS may contain information of significant diagnostic and physiological value regarding
the pulmonary parenchyma and vasculature, as well as the cardio-vascular system in general.
In a pilot clinical validation study of patients with acute decompensated heart failure
(ADHF) patients, LDS signals unique to ADHF patients were identified, that superpose on the
normal Lung Doppler Signals (unpublished data). These are high velocity "disorganized"
variable signals that are not synchronous with the cardiac cycle but rather sometimes with
respiration.
Study Purpose and Rationale
The purpose of this study is to assess the utility of noninvasive assessment of lung Doppler
signals performed via transthoracic parametric Doppler. The study has two major objectives
and is thus, divided into two phases, which are on a continuum.
Phase 1: The objective is to further evaluate LDS among patients presenting to the emergency
department with acute dyspnea, in order to determine the diagnostic value of this
non-invasive method to distinguish cardiac from pulmonary causes of dyspnea.
Phase 2: In addition, for those patients admitted to the hospital with a clinical diagnosis
of ADHF, we would like to further characterize changes in daily lung Doppler signal as a
surrogate biomarker of intravascular volume status, as assessed by clinical assessment.
Study Design and Methods:
1. Overall study design
Phase 1:
Prospective cohort study of patients presenting to the Massachusetts General Hospital
emergency department with acute dyspnea. . In addition, at MGH, pts admitted to the cardiac
floors (Ellison 9, 10, 11) and general medicine floors (White 9, 10, 11) with an admitting
diagnosis of heart failure, who presented with acute dyspnea, will be approached for
enrollment within 24 hours of hospital admission. All patients with acute dyspnea will
undergo routine clinical assessment, laboratory testing, and diagnostic imaging. In addition,
all patients will also undergo transthoracic parametric Doppler ultrasound based assessment
of LDS. Patients will be treated as usual, under the direction of the attending physician.
Two independent cardiologists will perform detailed chart review on all patients to determine
the etiology of acute dyspnea. They will be blinded to the results of the LDS. In the event
of discrepant findings, a third cardiologist will perform a final detailed chart review to
adjudicate the diagnosis.
Additionally, radiologist employed at MGH and who are independent to the study may perform
blinded adjudication of the study participants' chest x-rays (CXR) obtained in the Emergency
Department on the day of enrollment into the study
Phase 2:
In addition, patients diagnosed with ADHF (diagnosed based on the criteria described below),
will undergo daily TPD and assessment of LDS to further characterize changes in LDS over
time, until the day of discharge or up to day 7 of hospitalization, whichever comes first. In
addition to the initial inpatient scans, study staff will try to acquire a final scan within
72 hours of discharge for patients diagnosed with ADHF, regardless of the day of
hospitalization. This cohort of patients will also undergo daily clinical assessment of
volume status, weight measurement, and BNP assessment. In the event that repeat BNP or
NT-proBNP labs have not been drawn within 72 hours of discharge, study staff will coordinate
with the pathology laboratory (Dr. Kent Lewandrowski) to perform the assay as a research test
using excess clinical specimen from the subject's routine clinical blood draw if available.
Research subjects will not be charged for the cost of the BNP or NT-Pro-BNP assay.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04688905 -
Diagnosing Heart Failure With Preserved Ejection Fraction in Patients With Unexplained Dyspnea (Diagnose-HFpEF)
|
||
Completed |
NCT03679312 -
The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD
|
Phase 1/Phase 2 | |
Recruiting |
NCT04868357 -
Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program
|
N/A | |
Active, not recruiting |
NCT03604822 -
Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS
|
N/A | |
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Completed |
NCT02638649 -
Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
|
||
Completed |
NCT02538770 -
Rapid Viral Diagnostics in Adults to Reduce Antimicrobial Consumption and Duration of Hospitalization
|
N/A | |
Terminated |
NCT02269761 -
Chest Ultrasound of ER Patients With Cough or SOB
|
||
Recruiting |
NCT01655199 -
Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease
|
N/A | |
Active, not recruiting |
NCT01440764 -
Aerosol Inhalation Treatment for Dyspnea
|
Phase 1/Phase 2 | |
Completed |
NCT01577407 -
Non Opioid Treatment for Experimental Dyspnea
|
Phase 3 | |
Completed |
NCT01193998 -
Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department
|
N/A | |
Recruiting |
NCT04327882 -
Point-of-care Ultrasound Interest in Dyspneic Emergency Department Patients: an Observational Bicentric Study
|
||
Completed |
NCT05029986 -
Preventing Dyspnea During Speech in Older Speakers
|
N/A | |
Not yet recruiting |
NCT04181359 -
The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease.
|
Phase 1/Phase 2 | |
Recruiting |
NCT04615065 -
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
|
||
Completed |
NCT04305639 -
The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)"
|
||
Completed |
NCT04375917 -
Is Reduced Hypoxia Through a Robot Intervention, Associated With Sensory and Emotional Descriptions of Dyspnea, Anxiety, Depression, Symptom Burden and Anxiolytics
|
N/A | |
Completed |
NCT04370990 -
Automated Oxygen Administration -Rethinking Interventions Alleviating Dyspnea in Patients With COPD
|
N/A | |
Completed |
NCT04186754 -
Study of an Integral Respiratory Rehabilitation Program in Oncological Patient With Disney
|
N/A |